Nuveen Asset Management, LLC Biodesix Inc Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.32 - $2.12 $25,755 - $41,365
-19,512 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.09 - $8.67 $41,897 - $88,815
-10,244 Reduced 34.43%
19,512 $89,000
Q3 2021

Nov 12, 2021
BUY
$6.6 - $12.78 $67,610 - $130,918
10,244 Added 52.5%
29,756 $259,000
Q2 2021

Aug 16, 2021
BUY
$12.14 - $20.35 $236,875 - $397,069
19,512 New
19,512 $258,000

Others Institutions Holding BDSX

# of Institutions
59
Shares Held
62.2M
Call Options Held
2.6K
Put Options Held
10.1K
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $40.8M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email